SCHEMBL18474342

SCHEMBL18474342

CC(=O)N[C@H]1CCC[C@@H](C)C1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.53
KDM4E B2RXH2 2/20 0.53
ATM Q13315 2/20 0.47
EPHX1 P07099 7/20 0.42
CA12 O43570 2/20 0.41
CA9 Q16790 2/20 0.41
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
TLR4 O00206 1/20 0.40
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
BTK Q06187 1/20 0.38
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 1/20 0.37
CYP3A4 P08684 1/20 0.37
EPHX2 P34913 1/20 0.37
MMP2 P08253 1/20 0.36
MMP8 P22894 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14543527 1.00 ALDH1A1 (0.53) ALDH1A1KDM4EATMEPHX1CA12
SCHEMBL14098332 1.00 ALDH1A1 (0.53) ALDH1A1KDM4EATMEPHX1CA12
SCHEMBL10305534 1.00 ALDH1A1 (0.53) ALDH1A1KDM4EATMEPHX1CA12
SCHEMBL14885085 0.94 ALDH1A1 (0.60) ALDH1A1KDM4EATMEPHX1CA12
SCHEMBL14820161 0.87 ATM (0.50) ALDH1A1KDM4EATMEPHX1CA12
SCHEMBL18078660 0.87 ATM (0.50) ALDH1A1KDM4EATMEPHX1CA12
SCHEMBL15731518 0.87 ATM (0.50) ALDH1A1KDM4EATMEPHX1CA12
SCHEMBL18078661 0.87 ATM (0.50) ALDH1A1KDM4EATMEPHX1CA12
SCHEMBL26512382 0.87 ATM (0.50) ALDH1A1KDM4EATMEPHX1CA12
SCHEMBL26288090 0.87 ATM (0.50) ALDH1A1KDM4EATMEPHX1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021119249-A1 CYCLOPHILIN D INHIBITORS AND USES THEREOF THE BROAD INSTITUTE, INC. (US) 2021-06-17 WO disclosed
WO-2017023894-A1 MTHFD2 INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-02-09 WO disclosed